Epstein Barr Virus-Positive Lymphoproliferative Disorder Following Lymphodepletion for MAGE A4 Adoptive Cellular Therapy in a Patient with Synovial Sarcoma: A Case Report

Lymphoproliferative disorder (LPD) associated with viral reactivation is a known risk of immunocompromised patients. With development of novel cellular therapies utilizing lymphodepletion regimens in advanced cancer, the risk of LPDs should be a consideration. Here, we report a case of a 61-year-old...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Maggie, Jawed, Ghazal, Ganjoo, Kristen N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601716/
https://www.ncbi.nlm.nih.gov/pubmed/37900845
http://dx.doi.org/10.1159/000533129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601716/
https://www.ncbi.nlm.nih.gov/pubmed/37900845
http://dx.doi.org/10.1159/000533129

Ejemplares similares